Table 2.
Baseline characteristics of recipients with a CRKP-positive preservation fluid culture
| Characteristics | Recipients with graft loss or death | Recipients without graft loss or death | P Value |
|---|---|---|---|
| N = 6 | N = 14 | ||
| Sex, male n (%) | 5(83.3) | 10(71.4) | 0.573 |
| Age (years) | 36.8 ± 8.9 | 36.0 ± 11.8 | 0.879 |
| BMI (kg/m2) | 22.5 ± 3.8 | 22.4 ± 3.6 | 0.948 |
| Aetiology of kidney failure, n (%) | |||
| HTA | 1(16.7) | 1(7.1) | 0.521 |
| DM | 1(16.7) | 1(7.1) | 0.521 |
| Glomerulonephritis | 4(66.7) | 11(78.6) | 0.613 |
| Others | 0(0.0) | 1(7.1) | 0.502 |
| Type of dialysis n (%) | |||
| HD | 4(66.7) | 12(85.7) | 0.549 |
| PD | 2(33.3) | 2(14.3) | 0.549 |
| Duration of dialysis (years) median (IQR) | |||
| Duration of HD | 1.5(0.0-5.5) | 2.0(0.4-5.0) | 0.588 |
| Duration of PD | 0.0(0.0-1.8) | 0.0(0.0-0.0) | 0.345 |
| DGF n (%) | 1(16.7) | 5(35.7) | 0.613 |
| ATG induction n (%) | 2(33.3) | 5(35.7) | 0.919 |
| Pdd-CRKP infection (%) | 6(100.0) | 9(64.3) | 0.091 |
| Antibiotic regimen containing ceftazidime avibatan (%) | 1(16.7) | 11(78.6) | 0.018 |
Abbreviations: BMI body mass index, HTA hypertension, DM diabetes mellitus, HD haemodialysis, PD peritoneal dialysis, DGF delayed graft function, ATG anti-thymocyte globulin